170 related articles for article (PubMed ID: 20520630)
1. Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy.
Hiscutt EL; Hill DS; Martin S; Kerr R; Harbottle A; Birch-Machin M; Redfern CP; Fulda S; Armstrong JL; Lovat PE
J Invest Dermatol; 2010 Sep; 130(9):2250-8. PubMed ID: 20520630
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition.
Armstrong JL; Corazzari M; Martin S; Pagliarini V; Falasca L; Hill DS; Ellis N; Al Sabah S; Redfern CP; Fimia GM; Piacentini M; Lovat PE
Clin Cancer Res; 2011 Apr; 17(8):2216-26. PubMed ID: 21270111
[TBL] [Abstract][Full Text] [Related]
3. Targeting GRP78 to enhance melanoma cell death.
Martin S; Hill DS; Paton JC; Paton AW; Birch-Machin MA; Lovat PE; Redfern CP
Pigment Cell Melanoma Res; 2010 Oct; 23(5):675-82. PubMed ID: 20546536
[TBL] [Abstract][Full Text] [Related]
4. X-linked inhibitor of apoptosis protein as a therapeutic target in metastatic melanoma.
Tian F; Lee SW
J Invest Dermatol; 2010 Sep; 130(9):2169-72. PubMed ID: 20711206
[TBL] [Abstract][Full Text] [Related]
5. XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis.
Ehrenschwender M; Bittner S; Seibold K; Wajant H
Cell Death Dis; 2014 Dec; 5(12):e1570. PubMed ID: 25501831
[TBL] [Abstract][Full Text] [Related]
6. Targeting x-linked inhibitor of apoptosis protein for melanoma therapy: the need for more homogeneous samples and the importance of cell lines.
Kwatra SG
J Invest Dermatol; 2011 Mar; 131(3):797. PubMed ID: 21068753
[No Abstract] [Full Text] [Related]
7. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.
Fernández Y; Verhaegen M; Miller TP; Rush JL; Steiner P; Opipari AW; Lowe SW; Soengas MS
Cancer Res; 2005 Jul; 65(14):6294-304. PubMed ID: 16024631
[TBL] [Abstract][Full Text] [Related]
9. Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma.
Hill DS; Martin S; Armstrong JL; Flockhart R; Tonison JJ; Simpson DG; Birch-Machin MA; Redfern CP; Lovat PE
Clin Cancer Res; 2009 Feb; 15(4):1192-8. PubMed ID: 19228725
[TBL] [Abstract][Full Text] [Related]
10. Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells.
Armstrong JL; Flockhart R; Veal GJ; Lovat PE; Redfern CP
J Biol Chem; 2010 Feb; 285(9):6091-100. PubMed ID: 20022965
[TBL] [Abstract][Full Text] [Related]
11. [Effect of bortezomib on reverse multidrug resistance and XIAP expression in imatinib-resistant primary cells of chronic myeloid leukemia in blastic crisis].
Zhao J; Ma LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):899-904. PubMed ID: 23998582
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
[TBL] [Abstract][Full Text] [Related]
13. Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.
Hörnle M; Peters N; Thayaparasingham B; Vörsmann H; Kashkar H; Kulms D
Oncogene; 2011 Feb; 30(5):575-87. PubMed ID: 20856198
[TBL] [Abstract][Full Text] [Related]
14. Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib.
Lecis D; Drago C; Manzoni L; Seneci P; Scolastico C; Mastrangelo E; Bolognesi M; Anichini A; Kashkar H; Walczak H; Delia D
Br J Cancer; 2010 Jun; 102(12):1707-16. PubMed ID: 20461078
[TBL] [Abstract][Full Text] [Related]
15. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.
Lovat PE; Corazzari M; Armstrong JL; Martin S; Pagliarini V; Hill D; Brown AM; Piacentini M; Birch-Machin MA; Redfern CP
Cancer Res; 2008 Jul; 68(13):5363-9. PubMed ID: 18593938
[TBL] [Abstract][Full Text] [Related]
16. Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57.
Corazzari M; Lovat PE; Armstrong JL; Fimia GM; Hill DS; Birch-Machin M; Redfern CP; Piacentini M
Br J Cancer; 2007 Apr; 96(7):1062-71. PubMed ID: 17353921
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.
Jiang CC; Lucas K; Avery-Kiejda KA; Wade M; deBock CE; Thorne RF; Allen J; Hersey P; Zhang XD
Cancer Res; 2008 Aug; 68(16):6708-17. PubMed ID: 18701495
[TBL] [Abstract][Full Text] [Related]
18. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and XIAP expression in K562 cells].
Shao M; Sun L; Cui XY; Han XF; Chen SM; Wang F; Zhang H; Ling Z
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):182-6. PubMed ID: 21535957
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells.
Periyasamy-Thandavan S; Jackson WH; Samaddar JS; Erickson B; Barrett JR; Raney L; Gopal E; Ganapathy V; Hill WD; Bhalla KN; Schoenlein PV
Autophagy; 2010 Jan; 6(1):19-35. PubMed ID: 20110775
[TBL] [Abstract][Full Text] [Related]
20. Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.
Qin JZ; Xin H; Sitailo LA; Denning MF; Nickoloff BJ
Cancer Res; 2006 Oct; 66(19):9636-45. PubMed ID: 17018621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
